AeroLeads people directory · profile
Bruce Imbert Md, Phd, Mph Email & Phone Number
Founder and President
at
MindPath Pharma Consulting LLC
LinkedIn matched
✓ Verified May 2026
3 data sources
Profile completeness 100%
Current company
Role
Founder and President
Location
Richmond, Virginia, United States
Company size
Who is Bruce Imbert Md, Phd, Mph? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Bruce Imbert Md, Phd, Mph is listed as Founder and President at MindPath Pharma Consulting LLC, a company with 1 employees, based in Richmond, Virginia, United States. AeroLeads shows a matched LinkedIn profile for Bruce Imbert Md, Phd, Mph.
Bruce Imbert Md, Phd, Mph previously worked as Medicines Development Leader at Indivior and Standing member of the NIDA-L Medication Development Research Study Section (NIH/NIDA) at The National Institutes Of Health. Bruce Imbert Md, Phd, Mph holds Doctor Of Medicine (Md) from Aix-Marseille University.
Company email context
Email format at MindPath Pharma Consulting LLC
This section adds company-level context without repeating Bruce Imbert Md, Phd, Mph's masked contact details.
MindPath Pharma Consulting LLC
Review company-level records connected to Bruce Imbert Md, Phd, Mph before choosing the right outreach path.
Profile bio
About Bruce Imbert Md, Phd, Mph
Dr. Bruce Imbert is an entrepreneurial physician executive with over 20 years in the healthcare industry and over 15 years of clinical and strategic leadership in CNS therapeutics, specializing in addiction, psychiatry, and digital therapeutics. He has a proven track record in leading clinical development, securing non-dilutive funding, and navigating complex regulatory environments for groundbreaking therapeutics.Dr. Imbert is passionate about advancing treatments for substance use disorders and psychiatric conditions through innovation and collaboration. His expertise spans CNS therapeutics, digital health solutions, regulatory strategy, and early-to-late-stage clinical development, with a focus on patient-centered solutions.Having successfully led multiple clinical programs, Dr. Imbert brings deep experience in drug development from Phase I through commercialization. He has clinical development experience in numerous indications, including substance use disorders, schizophrenia, major depression, anxiety disorders, and ADHD. He has worked across diverse therapeutic modalities, including intranasal sprays, long-acting injectables, and oral formulations, with significant expertise in the psychedelic space, particularly in assessing scientific approaches and clinical development programs.In his pharmaceutical leadership roles, Dr. Imbert has gained extensive experience in global clinical development, regulatory submissions, and medical governance. He forges strategic partnerships that drive research, commercialization, and secure funding to support innovation.As part of his contributions to the field, Dr. Imbert was invited by the NIH Director to serve as a Member of the Medication Development Research Study Section within the National Institute on Drug Abuse (NIDA) Initial Review Group, where he collaborates on advancing treatments for substance use disorders and psychiatric comorbidities. He was also appointed by the French Minister of Social Affairs and Health to the National Commission of First Instance for the validation of competences in addiction medicine.As a cross-functional leader, Dr. Imbert brings a multicultural background and a unique perspective, making him adaptable and resourceful in problem-solving.Areas of expertise include:Clinical Development Strategy, CNS Therapeutics, Addiction & Psychiatry, Regulatory Submissions, Digital Health & Digital Therapeutics, Real-World Evidence, Translational Medicine, Non-Dilutive Funding, Lifecycle Management, Risk Management & Strategic Partnerships.
Listed skills include Leadership, Presentation Skills, Research And Development, Clinical Trials, and 46 others.
Current workplace
Bruce Imbert Md, Phd, Mph's current company
Company context helps verify the profile and gives searchers a useful next step.
Mindpath Pharma Consulting Llc
Employees
1
AeroLeads page
20 roles · 18 years
Bruce Imbert Md, Phd, Mph work experience
A career timeline built from the work history available for this profile.
Medicines Development Leader
CurrentI currently lead a team of development professionals focused on bringing new medicines to patients with substance use disorders.
Oct 2023 - Present
Standing Member Of The Nida-L Medication Development Research Study Section (Nih/Nida)
CurrentAppointed to a three-year term as a charter member of the Medication Development Research Study Section at the National Institute on Drug Abuse (NIDA)
Apr 2024 - Present
Nih/Nida Reviewer
CurrentReviewer for grant applications for the Study section "Development of Digital Therapeutics for Substance Use Disorders"
2022 - Present
~4 yrs 4 mos
Founder And Principal
CurrentProvided strategic advisory services to clients in the CNS and addiction therapeutic consulting field.Offered guidance on target product profiles and advancements in digital therapeutics for biotech and pharmaceutical industries.Assisted in developing clinical development plans and study designs for clients.
May 2023 - Present
Chief Medical Officer
Led Phase 1 clinical programs for addiction medicine, including SAD, MAD, and DDI studies, preparing for Phase 2 across multiple indications.Secured a $5.3M NIH/NIDA grant, funding clinical/non-clinical Phase 1 programs and supporting the groundwork for further Phase 2 studies.Built strategic KOL partnerships across the US, Europe, and South America to.
Mar 2021 - May 2023
Senior Global Clinical Development Lead
Pear Therapeutics
Directed R&D for Substance Use Disorder and Psychiatry programs, advancing the safety and efficacy of digital therapeutics through clinical trials.Secured $1.2M in NIH/NIDA funding for digital therapeutics targeting opioid use disorder.Developed clinical roadmaps and life cycle management plans, contributing to regulatory submissions (IND, NDA/510(K).
Feb 2019 - Feb 2021
Founder And Principal
Founded and led ACR Healthcare Consulting, providing expert guidance to pharma and biotech sectors.Collaborated with top clients like Reckitt Benckiser and Merck Serono on clinical development and communication.Achieved successful outcomes in clinical education and development projects for leading pharmaceutical companies.
2013 - 2021
~8 yrs
Medical Director - Clinical Lead Physician | Global Medicines Development
As Medical Director and Clinical Lead Physician at Indivior, I was responsible for the medical and scientific oversight of clinical trials in substance use disorder and psychiatry, from early to late phases. I also ensured the quality and safety of clinical data and regulatory submissions, leading to successful NDAs in the US and EU. I spearheaded clinical.
2016 - 2019
~3 yrs
Fellow In Global Translational Medicine
As Fellow in Global Translational Medicine, I was involved in designing and evaluating clinical studies for substance use disorders and psychiatric comorbidities. I also anticipated and mitigated challenges and risks in program and development plans. I established and maintained effective collaborations with KOLs and academics in the US and EU to support.
2015 - 2016
~1 yr
Scientific Advisor
Advisory Board member, KOL engagements, and consulting in the Substance Use Disorder and Mental Health Therapeutic arena.
2014 - 2015
~1 yr
Post-Doctoral Fellowship At Umr 912 Sesstim/Inserm
Scientific Advisor and Principal Investigator for a Phase II Pilot study to evaluate the effectiveness and tolerance of methylphenidate for the treatment of cocaïne dependence.
2012 - 2016
~4 yrs
Adjunct Professor, Addiction Medicine & Clinical Pharmacology
I have served as a Principal Investigator or Co-Investigator on a number of clinical trials, focusing on the development of novel treatments for substance use disorders, particularly alcohol, psychostimulants (such as cocaine and amphetamines), and cannabis. My educational activities have included lecturing to medical students, Psychiatry residents, and.
2013 - 2015
~2 yrs
Vice President And Board Member
Developed organizational resources to optimize coordination for patients with addictive and psychiatric disorders.Implemented innovative strategies to improve patient care and treatment outcomes.Led cross-functional teams to drive collaboration and efficiency within the organization.
Nov 2012 - 2015
Attending Physician And Clinical Investigator
Led integrated treatment for substance use and co-occurring psychiatric disorders, incorporating methadone, buprenorphine, and targeted behavioral therapies like CBT and MBCT.Spearheaded medical research in baclofen's clinical pharmacology for alcohol dependence, guiding phase II/III studies.Collaborated closely with academic, governmental, and industry.
2012 - 2015
~3 yrs
Instructor In Mindfulness-Based Relapse Prevention (Mbrp) For Addictive Behaviors
Led Mindfulness-Based Relapse Prevention (MBRP) and MBCT classes for patients with Substance Use Disorders and Mental Health Disorders.Conducted research on neural mechanisms and clinical efficacy of mindfulness training using fMRI technology.Taught MBCT and Mindfulness-Based Stress Reduction (MBSR) to medical students.
2012 - 2015
~3 yrs
Resident In Addiction Medicine/Psychiatry
Provided consultations and integrated treatment for patients with substance use disorders (alcohol, nicotine, stimulants, cannabis, and opioid use disorder, including methadone and buprenorphine maintenance treatment) and co-occurring psychiatric comorbidities (depression, bipolar disorder, ADHD, psychotic disorder, anxiety).
2011 - 2012
~1 yr
Resident In Medicine
Therapeutic experience in Internal Medicine, Cardiology, Oncology, Pneumology, Pediatric/Adult Emergency Medicine, Primary care Medicine, Psychiatry & Addiction Medicine.
2008 - 2012
~4 yrs
Principal Investigator
Principal Investigator on a Phase III Randomized, Multicentric, Double Blind Study to Assess the Efficacy of Xylka® (Baclofen) at the Target Dosage of 180mg/Day Compared to Placebo, for Maintenance of Abstinence in Alcohol Dependent PatientsALPADIR Study. ClinicalTrials.gov Identifier: NCT01738282
Feb 2013 - Jul 2014
Principal Investigator
Allauch Hospital Center
Principal Investigator for a Phase II Pilot study to evaluate the effectiveness and tolerance of methylphenidate for the treatment of cocaïne dependence in collaboration with UMR 912 SESSTIM (INSERM-IRD- AMU)
2013 - 2014
~1 yr
8 education records
Bruce Imbert Md, Phd, Mph education
Doctor Of Medicine (Md)
Aix-Marseille University
Doctor Of Philosophy (Phd), Clinical Research/Pharmacology
Aix-Marseille University
Masters Of Public Health (Mph)
Aix-Marseille University
Technology Entrepreneurship: Lab To Market
Harvardx
Postgraduate Diploma Of Complementary Specialized Studies (Desc), Pharmacokinetics And Drug Metabolism
Aix-Marseille University
College Certificate, Medical It & Communication Technology
Aix-Marseille University
College Certificate, General Pharmacology
Aix-Marseille University
Studied, Finances And International Business (Esc Marseille/Isefi; Currently Kedge Business School)
Kedge Business School
FAQ
Frequently asked questions about Bruce Imbert Md, Phd, Mph
Quick answers generated from the profile data available on this page.
What company does Bruce Imbert Md, Phd, Mph work for?
Bruce Imbert Md, Phd, Mph works for MindPath Pharma Consulting LLC.
What is Bruce Imbert Md, Phd, Mph's role at MindPath Pharma Consulting LLC?
Bruce Imbert Md, Phd, Mph is listed as Founder and President at MindPath Pharma Consulting LLC.
Where is Bruce Imbert Md, Phd, Mph based?
Bruce Imbert Md, Phd, Mph is based in Richmond, Virginia, United States while working with MindPath Pharma Consulting LLC.
What companies has Bruce Imbert Md, Phd, Mph worked for?
Bruce Imbert Md, Phd, Mph has worked for Mindpath Pharma Consulting Llc, Indivior, The National Institutes Of Health, Tempero Bio, and Pear Therapeutics.
How can I contact Bruce Imbert Md, Phd, Mph?
You can use AeroLeads to view verified contact signals for Bruce Imbert Md, Phd, Mph at MindPath Pharma Consulting LLC, including work email, phone, and LinkedIn data when available.
What schools did Bruce Imbert Md, Phd, Mph attend?
Bruce Imbert Md, Phd, Mph holds Doctor Of Medicine (Md) from Aix-Marseille University.
What skills is Bruce Imbert Md, Phd, Mph known for?
Bruce Imbert Md, Phd, Mph is listed with skills including Leadership, Presentation Skills, Research And Development, Clinical Trials, Cns Disorders, Psychiatry, Public Speaking, and Digital Products.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial